Table 1 Clinical characteristics of the patients and histopathological parameters of the tumors of breast cancer (DCIS and carcinoma) patients (primary diagnosis, nā=ā214)
From: The impact of CBP expression in estrogen receptor-positive breast cancer
Variables | N (%) | No. of missing data (%) | Variables | N (%) | No. of missing data (%) |
|---|---|---|---|---|---|
Age at diagnosis (years) | Ā | 0 (0.0) | ER statusa | Ā | 9 (4.2) |
āā¤ā40 | 15 (7.0) | Ā | Negative | 78 (38.0) | Ā |
41ā70 | 127 (59.4) | Ā | Positive | 127 (62.0) | Ā |
ā>ā70 | 72 (33.6) | Ā | Ā | Ā | Ā |
Tumor stage | Ā | 29 (13.6) | PR statusa | Ā | 13 (6.1) |
pTis | 6 (3.2) | Ā | Negative | 75 (37.3) | Ā |
pT1 | 51 (27.6) | Ā | Positive | 126 (62.7) | Ā |
pT2 | 80 (43.2) | Ā | HER2 overexpression | Ā | 7 (3.3) |
pT3 | 8 (4.3) | Ā | Negative | 184 (88.9) | Ā |
pT4 | 40 (21.6) | Ā | Positive (>ā30%) | 23 (11.1) | Ā |
Histological grade | Ā | 21 (9.8) | Ki67 status | Ā | 2 (0.9) |
G1 | 8 (4.1) | Ā | ā¤ā20% | 188 (88.7) | Ā |
G2 | 149 (77.2) | Ā | >ā20% | 24 (11.3) | Ā |
G3 | 36 (18.7) | Ā | Ā | Ā | Ā |
Lymph node metastasis | Ā | 45 (21.0) | Subtypes [58] | Ā | 41 (19.2) |
Negative | 84 (49.7) | Ā | Luminal A | 86 (49.7) | Ā |
Positive | 85 (50.3) | Ā | Luminal B HER2ā | 23 (13.3) | Ā |
| Ā | Ā | Ā | Luminal B HER2+ | 10 (5.8) | Ā |
| Ā | Ā | Ā | HER2-overexpressed | 9 (5.2) | Ā |
| Ā | Ā | Ā | Triple negative | 45 (26.0) | Ā |